secwatch.observer — SEC 8-K summary
======================================

Issuer:     ACURA PHARMACEUTICALS, INC (—)
CIK:        0000786947
Form:       8-K
Filed at:   2025-04-23T23:59:59+00:00
Accession:  0001104659-25-037976
Event type: debt
Sentiment:  negative
Materiality: 0.90
Item codes: 1.01, 2.01, 2.03, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Acura receives $200K in new loans from controlling shareholder; debt due May 31, warns of possible bankruptcy
--------------------------------------------------------------------------------

- Secured note principal now $7,794,279 with ~$650,000 accrued interest; 5.25% interest rate, due May 31, 2025.
- New $100,000 loans from controlling shareholder AD Pharma on April 4 and April 18, 2025; AD Pharma owns ~65% of Acura common stock.
- If not paid by May 31, 2025, overdue amounts bear default interest at 7.5% per annum.
- Without additional financing by mid-May 2025, Acura warns it may scale back operations, furlough employees, or seek bankruptcy; total loss of shareholder value possible.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/786947/000110465925037976/0001104659-25-037976-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/786947/000110465925037976/tm2513007d1_8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-037976

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer